Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. It offers software that is compatible with off-the-shelf, mobile client devices, which enables clinicians to communicate with remotely located documentation specialists (RDSs). The company's services include Augmedix Live, a real time service, in which RDSs provide medical documentation and live clinical support services; and Augmedix Notes, a non-real time product where RDSs offer medical documentation based upon recorded visits. Its clients include health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$5.58    OTCQX
As of 10/22/2021     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Index country:  USA
Country of incorporation:  
IPO date:  08/09/2021
Outstanding shares:  27,151,424
Average volume:  1,647
Market cap:   $151,331,824
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -8.68
PB ratio:   -32.29
PS ratio:   10.64
Return on equity:   204.08%
Net income %:   -67.31%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy